Mobile

Study conducted on humans in Europe to test the importance of a small molecule normally produced by the body, called Interleukin 2 (IL-2) to treat a specific type of diabetes (called type 1 diabetes)

Update Il y a 4 ans
Reference: EUCTR2014-002522-12

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

1. To evaluate efficacy of ILT-101 for the preservation of residual pancreatic β cells function 2. To select the optimal regimen of administration of ILT- 101

Inclusion criteria

  • type -I diabetes

Links